Learn more Medtronic is to acquire SPR Therapeutics for an upfront cash payment of nearly $650m, expanding care options for ...
Medtronic acquire pain management devicemaker SPR Therapeutics for $650M to expand neuromodulation with peripheral nerve stimulation technology.
Medtronic plc MDT announced its intent to acquire SPR Therapeutics, Inc. (“SPR”), a privately held medical technology company and a recognized leader in temporary, percutaneous peripheral nerve ...
SPRINT PNS is now recognized as a covered treatment option when medically necessary for certain patients with intractable neuropathic pain Under Aetna’s updated medical policy, the SPRINT PNS System ...
CARLSBAD, Calif.--(BUSINESS WIRE)--Nalu Medical Inc. (“Nalu”) revealed significant findings from a landmark clinical trial evaluating the Nalu Peripheral Nerve Stimulation (PNS) System utilizing their ...
POMPANO BEACH, Fla., March 27, 2025 (GLOBE NEWSWIRE) -- Curonix LLC, a leading medical technology company specializing in relieving chronic pain without the use of opioids, proudly introduces ...
CLEVELAND, July 15, 2024 (GLOBE NEWSWIRE) -- Five abstracts featuring SPR Therapeutics’ SPRINT PNS System generated interest from leading pain physicians at the American Society of Pain & Neuroscience ...
The peripheral nervous system (PNS) is the system of nerves and ganglia outside the brain and spinal cord. The PNS consists of the peripheral nerves, neuromuscular junctions, cranial nerves, and ...
SPRINT PNS is now recognized as a covered treatment option when medically necessary for certain patients with intractable neuropathic pain CLEVELAND, March 13, 2026 (GLOBE NEWSWIRE)-- SPR®, a leading ...